Evidence map›Paper›PMID 35750343›Full record

ArticleBMJ global health2022

Experience of field testing in Lebanon during the COVID-19 pandemic, January to August 2021.

Zeina Farah, Nada Ghosn, Tatiana Tohme, Hala Abou Naja, Reem Abdel Malak, Hawraa Sweidan, Hamad Hassan

Abstract read
In one paragraph

Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zeina FarahMinistry of Public Health, Epidemiological Surveillance Program, Beirut, Lebanon zfarah.esu@gmail.com.ORCID 0000-0002-1961-2600
Nada GhosnMinistry of Public Health, Epidemiological Surveillance Program, Beirut, Lebanon.ORCID 0000-0003-3549-703X
Tatiana TohmeMinistry of Public Health, Epidemiological Surveillance Program, Beirut, Lebanon.
Hala Abou NajaMinistry of Public Health, Epidemiological Surveillance Program, Beirut, Lebanon.
Reem Abdel MalakMinistry of Public Health, Epidemiological Surveillance Program, Beirut, Lebanon.
Hawraa SweidanMinistry of Public Health, Epidemiological Surveillance Program, Beirut, Lebanon.
Hamad HassanLebanese University, Faculty of Public Health, Laboratory Sciences Department, Zahleh, Lebanon.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Soon after detection of the first COVID-19 case in Lebanon, a testing strategy was developed aiming to early detect new cases and identify close contacts in order to implement isolation and quarantine measures, thus limiting disease transmission. Field-testing activities were initiated in March 2020, focusing on suspected cases and close contacts. The objective of this paper is to present data collected between the 1st and the 35th week of 2021 and discuss challenges and lessons learned. During the study period, testing activities were conducted in field sites covering all Lebanese districts and following a fixed schedule. Testing was provided free of charge for suspected/probable patients with COVID-19 and close contacts of positive cases. Nasopharyngeal specimens were collected and sent to designated laboratories for reverse transcription polymerase chain reaction testing. Results were received on a timely manner, within 48 hours. From the 1st to the 35th week of 2021, 1244 field-testing activities were conducted with an average of 37 testing activities per week. During this period, 71 542 samples were collected with an average of 2104 specimens per week. On average, activities covered 78% of the Lebanese districts. The average positivity rate for this period was 24% (15%-33%) in line with the virus circulation levels in the country. Timely development and implementation of a testing strategy is crucial during epidemics. The success of Lebanon's field-testing experience was mainly due to the timely adapted approach that covered all national territories, targeting all residents as well as high-risk groups in suburbs and remote areas.

Indexed as

COVID-19COVID-19 TestingHumansLebanonPandemicsQuarantineCOVID-19descriptive studypublic health

Identifiers

PMID35750343
PMCPMC9234433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.